Oppenheimer & Co’s iShares iBonds Dec 2028 Term Corporate ETF IBDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$392K Sell
15,516
-5,923
-28% -$150K ﹤0.01% 1375
2026
Q1
$543K Buy
21,439
+1,628
+8% +$41.4K 0.01% 1159
2025
Q4
$504K Buy
19,811
+1,309
+7% +$33.3K 0.01% 1070
2025
Q3
$472K Buy
18,502
+1,554
+9% +$39.5K 0.01% 1193
2025
Q2
$431K Buy
16,948
+332
+2% +$8.37K 0.01% 1196
2025
Q1
$420K Buy
16,616
+755
+5% +$18.9K 0.01% 1136
2024
Q4
$395K Buy
15,861
+126
+0.8% +$3.16K 0.01% 1160
2024
Q3
$402K Buy
+15,735
New +$397K 0.01% 1120

Other funds holding IBDT

Oppenheimer & Co's IBDT Position: Q2 2026 in Review

Oppenheimer & Co reduced its iShares iBonds Dec 2028 Term Corporate ETF (IBDT) stake by 28% in Q2 2026, selling an estimated $150K and leaving 15,516 shares worth $392K. The position accounts for ﹤0.01% of the portfolio, ranked #1375.

Oppenheimer & Co first reported a position in IBDT in Q3 2024 and has held it in 8 quarters since. The position peaked at $543K in Q1 2026. 435 funds tracked by Wall St. Rank hold IBDT as of Q2 2026.

  • Oppenheimer & Co held 15,516 shares of iShares iBonds Dec 2028 Term Corporate ETF worth $392K as of Q2 2026.
  • Oppenheimer & Co sold 5,923 iShares iBonds Dec 2028 Term Corporate ETF shares in Q2 2026, an estimated $150K.
  • iShares iBonds Dec 2028 Term Corporate ETF made up ﹤0.01% of Oppenheimer & Co's portfolio in Q2 2026, its #1375 holding.
  • Oppenheimer & Co first reported a position in iShares iBonds Dec 2028 Term Corporate ETF in Q3 2024 and has held it in 8 quarters since.
  • Oppenheimer & Co's iShares iBonds Dec 2028 Term Corporate ETF position peaked at $543K in Q1 2026.
  • 435 funds tracked by Wall St. Rank held iShares iBonds Dec 2028 Term Corporate ETF as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.